Palatin Technologies (PTN) Inventory Average (2020 - 2023)
Palatin Technologies' (PTN) quarterly Inventory Average came in at $1.1 million in Q3 2023, up 17.85% YoY from $901223.0 in Q3 2022, and up 83.75% on a QoQ basis from $578016.5 in Q2 2023.
Palatin Technologies (PTN) Inventory Average (2020 - 2023) Analysis & Trends
Palatin Technologies (PTN) has 4 years of Inventory Average data on file, last reported at $1.1 million in Q3 2023.
- Quarterly Inventory Average rose 17.85% year-over-year to $1.1 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $1.1 million (up 17.85% YoY) and the FY2023 annual result came in at $735235.5, down 30.19% from the prior year.
- Inventory Average advanced to $1.1 million in Q3 2023, from $578016.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $6.1 million in Q1 2021 to a low of $578016.5 in Q2 2023.
- A 4-year average of $2.0 million and a median of $1.1 million in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average tumbled 82.62% — and 2023, when it grew 17.85%.
- Tracing PTN's Inventory Average over 4 years: stood at $5.9 million in 2020, then sank by 81.5% to $1.1 million in 2021, then declined by 26.05% to $808621.5 in 2022, then surged by 31.35% to $1.1 million in 2023.
- The last three Inventory Average figures came in at $1.1 million (Q3 2023), $578016.5 (Q2 2023), and $694650.5 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | Palatin Technologies | 39.40 Mn | 39.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 578,016.50 |
| Mar 31, 2023 | 694,650.50 |
| Dec 31, 2022 | 808,621.50 |
| Sep 30, 2022 | 901,223.00 |
| Jun 30, 2022 | 988,229.50 |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 3.64 Mn |
| Mar 31, 2021 | 6.07 Mn |
| Dec 31, 2020 | 5.91 Mn |